HC-1144

N/A

Report date: 2025/02/28 11:25:04
NME

Base Information

Drug NameHC-1144
Drug Alias Namedeuterated tivozanib (Sichuan University/Chengdu Institute Of Organic Chemistry Chinese Academy Of Sciences/Hinova Pharmaceuticals Inc)HC-1144
ClassificationSmall molecules > Heterocyclic drugsSmall molecules > Deuterated drugs
Mechanisms of ActionPlatelet-derived growth factor receptor inhibitorsVascular endothelial growth factor receptor 1 antagonistsVascular endothelial growth factor receptor 2 antagonists +[6] 
TargetsVascular endothelial growth factor receptor 1Mitogen-activated protein kinaseVascular endothelial growth factor receptor 3 +[6] 
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesSichuan University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesChengdu Organic Chmistry Co Ltd Chinese Academy Of SciencesSichuan UniversityHinova Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A